An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation

Chronic antibody-mediated rejection (AMR) is a key limiting factor for the clinical outcome of a kidney transplantation (Ktx), where early diagnosis and therapeutic intervention is needed. This study describes the identification of the biomarker CXC-motif chemokine ligand (CXCL) 9 as an indicator fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Seiler, Lisa K., Phung, Ngoc Linh, Nikolin, Christoph, Immenschuh, Stephan, Erck, Christian, Kaufeld, Jessica, Haller, Hermann, Falk, Christine S., Jonczyk, Rebecca, Lindner, Patrick, Thoms, Stefanie, Siegl, Julia, Mayer, Günter, Feederle, Regina, Blume, Cornelia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871475/
https://www.ncbi.nlm.nih.gov/pubmed/35204399
http://dx.doi.org/10.3390/diagnostics12020308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871475/
https://www.ncbi.nlm.nih.gov/pubmed/35204399
http://dx.doi.org/10.3390/diagnostics12020308

Ejemplares similares